Saturday, October 25, 2014 7:30:17 PM
I’m still waiting for someone to approach me with a logical and at least semi coherent argument for why a company with a state of the art facility, cash on hand for the next 12 months minimum, multiple licensing contracts, funding from the Bill & Melinda Gates Foundation, a former advisor to Presidents Clinton & Bush on their Board of Directors, and.... offering their technology directly to the Federal Government in the Ebola crisis is a pump & dump? Because you said so? Because a hack law firm that has nothing to lose and everything to gain by adversely affecting IBIO’s share price said so? I hope you’re better than that. You’re going to have to be.
I traded pennies for 10 years. I’ve seen all of the scams and heard all of the stories. P&D’s don’t care if they are on the OTC, Pinksheets or a roll of toilet paper. IBIO has taken steps to ensure they remain on the AMEX while their stock is beaten to hell by day traders and shorts. IBIO doesn’t regard itself as a penny and image while you’re dealing on such a high level is extremely important. What you have here is simple market manipulation by pro’s who know damn well that the market over reacts to any news good or bad, and they take measures to profit from it.
Anybody reading this who has a position in IBIO and is unsure about it, get out. Because you probably don’t know enough about the underbelly of the market that preys on you. Jackals like Rosen and the current paid bashers attacking the message boards who are hired by firms short on Ebola stocks like IBIO, use your good nature against you. Good luck.
Recent IBIO News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/15/2024 01:47:49 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:48:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:27:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:06:21 PM
- iBio Reports Fiscal First Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 01:12:33 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/10/2024 08:16:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2024 08:10:53 PM
- iBio and AstralBio Provide Update on Myostatin Program for Obesity • GlobeNewswire Inc. • 10/10/2024 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/24/2024 08:11:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/20/2024 08:14:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:07:16 PM
- iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 09/20/2024 08:05:00 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development • GlobeNewswire Inc. • 08/12/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/06/2024 09:02:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 01:03:41 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 09:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
- iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM